Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1S3K

Crystal Structure of a Humanized Fab (hu3S193) in Complex with the Lewis Y Tetrasaccharide

Summary for 1S3K
Entry DOI10.2210/pdb1s3k/pdb
Related PRD IDPRD_900124
DescriptorHU3S193 Fab fragment, light chain, HU3S193 Fab fragment, heavy chain, alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-(1-4)-[alpha-L-fucopyranose-(1-3)]2-acetamido-2-deoxy-alpha-D-glucopyranose, ... (5 entities in total)
Functional Keywordsimmunoglobulin fold, beta barrel, humanized antibody, antigen binding fragment, immune system
Biological sourceMus musculus (house mouse)
More
Total number of polymer chains2
Total formula weight48631.07
Authors
Ramsland, P.A.,Farrugia, W.,Bradford, T.M.,Hogarth, P.M.,Scott, A.M. (deposition date: 2004-01-13, release date: 2004-07-13, Last modification date: 2024-10-30)
Primary citationRamsland, P.A.,Farrugia, W.,Bradford, T.M.,Hogarth, P.M.,Scott, A.M.
Structural convergence of antibody binding of carbohydrate determinants in lewis y tumor antigens
J.Mol.Biol., 340:809-818, 2004
Cited by
PubMed Abstract: Antibodies targeting human epithelial carcinomas bearing Lewis Y (Le(y)) carbohydrate antigens provide a striking illustration of convergent immune recognition. We report a 1.9A resolution crystal structure of the Fab of a humanized antibody (hu3S193) in complex with the Le(y) tetrasaccharide, Fuc(alpha 1-->2)Gal(beta 1-->4)[Fuc(alpha 1-->3)]GlcNAc. Comparisons of the hu3S193 and BR96 antibodies bound to Le(y) tumor antigens revealed extremely similar mechanisms for recognition of the carbohydrate epitopes. Solvent plays a critical role in hu3S193 antibody binding to the Le(y) carbohydrate epitope. Specificity for Le(y) is maintained because a conserved pocket accepts an N-acetyl group of the core Gal(beta 1-->4)GlcNAc disaccharide. Closely related blood-group determinants (Le(a) and Le(b)) cannot enter the specificity pocket, making the Le(y) antibodies promising candidates for immunotherapy of epithelial cancer.
PubMed: 15223322
DOI: 10.1016/j.jmb.2004.05.037
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon